New strategies to overcome imatinib resistance in treatment for chronic myelocytic leukemia.
- Author:
He LIU
;
Xiao-Guang CHEN
- Publication Type:Journal Article
- MeSH:
Animals;
Antineoplastic Agents;
therapeutic use;
Benzamides;
Dasatinib;
Drug Resistance, Neoplasm;
drug effects;
Fusion Proteins, bcr-abl;
genetics;
metabolism;
Humans;
Imatinib Mesylate;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;
drug therapy;
genetics;
metabolism;
Piperazines;
therapeutic use;
Protein-Tyrosine Kinases;
antagonists & inhibitors;
Pyrimidines;
pharmacology;
therapeutic use;
Thiazoles;
pharmacology;
therapeutic use
- From:
Chinese Journal of Oncology
2006;28(8):561-563
- CountryChina
- Language:Chinese
